A new Northwestern Medicine study has found that, following transplant and in chronic disease states, abnormal cells emerge and “conversations” between them drive the development of transplant rejection. The post New Study Gives Answers, Drug Targets for Chronic Lung-transplant Rejection appeared first on News Center.
